EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro

Robin Jansen iD, Marc Pawlitzki, Michael Gliem, Sven G Meuth, Stefanie Schreiber, Michael-W Görtler, Jens Neumann

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0314020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Robin Jansen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty and University Hospital Düsseldorf, Department of Neurology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany. Hauptthemen laut MEDLINE: Microglia, Glucose, Oxygen, Hippocampus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

For the last 38 years, all neuroprotective agents for patients with ischemic stroke have failed in clinical trials. The innate immune system, particularly microglia, is a much-discussed target for neuroprotective agents. Promising results for neuroprotection by inhibition of integrins with drugs such as natalizumab in animal stroke models have not been translated into clinical practice. Our present study reveals the relevance of a β2 integrin, lymphocyte function-associated antigen-1 (LFA-1), as a potential key player in protecting neuronal cell death after oxygen-glucose deprivation in organotypic hippocampal cell cultures. In addition, we identified microglial cells as effector cells for LFA-1-mediated neuroprotection. The counterpart of LFA-1 on microglia is unclear, but we show strong expression of ICAM-5 in hippocampal neurons, suggesting a critical role for direct crosstalk between microglia and neurons for neuronal survival under oxygen-glucose deprivation. The enigma of neuroprotection after ischemic stroke remains to be solved, and our findings highlight the continuing importance and lack of understanding of integrin-mediated pathways after ischemic stroke and the need for further intensive research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaGlucoseOxygenHippocampusLymphocyte Function-Associated Antigen-1NeuroprotectionNeuronsAnimalsRatsCells, CulturedMiceCell HypoxiaNeuroprotective Agents

Substanzen

GlucoseOxygenLymphocyte Function-Associated Antigen-1Neuroprotective Agents

Autor:innen und Institutionen

  • Medical Faculty and University Hospital Düsseldorf, Department of Neurology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany.
  • Medical Faculty, Department of Neurology, Otto von Guericke University, Magdeburg, Germany.

ORCID-Profile: Robin Jansen

Zitieren

APA

Jansen, R., Pawlitzki, M., Gliem, M., Meuth, S. G., Schreiber, S., Görtler, M. W., & Neumann, J. (2025). LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro. PLOS ONE. https://doi.org/10.1371/journal.pone.0314020

Vancouver

Jansen R, Pawlitzki M, Gliem M, Meuth SG, Schreiber S, Görtler MW, et al. LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro. PLOS ONE. 2025. doi:10.1371/journal.pone.0314020

BibTeX
@article{Jansen2025,
  author = {Jansen, Robin and Pawlitzki, Marc and Gliem, Michael and Meuth, Sven G and Schreiber, Stefanie and Görtler, Michael-W and Neumann, Jens},
  title = {LFA-1: A potential key player in microglia-mediated neuroprotection against oxygen-glucose deprivation in vitro},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0314020}
}
Kostenlos starten →